| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Wave Life Sciences Ltd. (WVE) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. WVE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 26.98M | $162.39M | - | |
| Dir | 5.73M | $34.49M | - | |
| Other | 408.2K | $2.46M | - | |
| Dir | 283.2K | $1.70M | - | |
| CEO | 275.5K | $1.66M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2020 | Vargeese Chandra | Senior VP, Drug Discovery | Sell | 3,188 | $7.85 | $25,025.80 | -7.9% | |
| Feb 18, 2020 | Panzara Michael A. | Chief Medical Officer | Sell | 2,981 | $7.85 | $23,400.85 | -7.0% | |
| Feb 18, 2020 | Bolno Paul64 | President And CEO | Sell | 11,451 | $7.85 | $89,890.35 | -3.5% | |
| Feb 3, 2020 | Gaiero David G | Interim CFO | Sell | 651 | $7.00 | $4,557.00 | -9.2% | |
| Dec 3, 2019 | Vargeese Chandra | Senior VP, Drug Discovery | Sale+OE | 6,000 | $35.00 | $210,000.00 | -13.0% | |
| Nov 20, 2019 | Verdine Gregory L.63 | Director | Sell | 30,039 | $30.63 | $920,212.76 | -23.3% | |
| Jul 5, 2019 | Panzara Michael A. | Chief Medical Officer | Sell | 3,058 | $26.94 | $82,368.14 | -3.5% | |
| Mar 15, 2019 | Bolno Paul64 | President And CEO | Sale+OE | 50,000 | $45.48 | $2,273,803.74 | -3.6% | |
| Mar 11, 2019 | Panzara Michael A. | Franchise Lead, Neurology | Sell | 7,000 | $48.00 | $336,000.00 | -13.4% | |
| Feb 19, 2019 | Regnante Keith | Chief Financial Officer | Sell | 1,298 | $36.84 | $47,817.80 | -7.6% |